1. Home
  2. SACH vs NOTV Comparison

SACH vs NOTV Comparison

Compare SACH & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SACH
  • NOTV
  • Stock Information
  • Founded
  • SACH 2010
  • NOTV 1974
  • Country
  • SACH United States
  • NOTV United States
  • Employees
  • SACH N/A
  • NOTV N/A
  • Industry
  • SACH Real Estate Investment Trusts
  • NOTV Biotechnology: Pharmaceutical Preparations
  • Sector
  • SACH Real Estate
  • NOTV Health Care
  • Exchange
  • SACH Nasdaq
  • NOTV Nasdaq
  • Market Cap
  • SACH 54.4M
  • NOTV 57.7M
  • IPO Year
  • SACH 2017
  • NOTV 1997
  • Fundamental
  • Price
  • SACH $1.25
  • NOTV $1.37
  • Analyst Decision
  • SACH Hold
  • NOTV Strong Buy
  • Analyst Count
  • SACH 4
  • NOTV 1
  • Target Price
  • SACH $2.25
  • NOTV $5.00
  • AVG Volume (30 Days)
  • SACH 246.4K
  • NOTV 394.8K
  • Earning Date
  • SACH 11-13-2025
  • NOTV 08-06-2025
  • Dividend Yield
  • SACH 15.94%
  • NOTV N/A
  • EPS Growth
  • SACH N/A
  • NOTV N/A
  • EPS
  • SACH N/A
  • NOTV N/A
  • Revenue
  • SACH N/A
  • NOTV $505,299,000.00
  • Revenue This Year
  • SACH N/A
  • NOTV $5.64
  • Revenue Next Year
  • SACH $7.74
  • NOTV $5.16
  • P/E Ratio
  • SACH N/A
  • NOTV N/A
  • Revenue Growth
  • SACH N/A
  • NOTV 0.85
  • 52 Week Low
  • SACH $0.80
  • NOTV $1.15
  • 52 Week High
  • SACH $2.70
  • NOTV $6.48
  • Technical
  • Relative Strength Index (RSI)
  • SACH 52.08
  • NOTV 32.94
  • Support Level
  • SACH $1.26
  • NOTV $1.36
  • Resistance Level
  • SACH $1.35
  • NOTV $1.68
  • Average True Range (ATR)
  • SACH 0.06
  • NOTV 0.11
  • MACD
  • SACH 0.00
  • NOTV -0.02
  • Stochastic Oscillator
  • SACH 44.74
  • NOTV 4.00

About SACH Sachem Capital Corp.

Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

Share on Social Networks: